CLINICAL_TRIALS
trial_result
· 2022-07-25
Clinical Trial Update: A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease [Phase 2]
Summary
A Phase 2 study evaluating RPL554 delivered via metered dose inhaler for chronic obstructive pulmonary disease has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2022-07-25